Document is current
Any future updates will be listed below
-
Authors
Marjo, Nylund
Jussi, Lehto
Markus, Matilainen
Johan, Rajander
Saara, Wahlroos
Marcus, Sucksdorff
Tanja, Kuhlmann
Laura, Airas
-
Funding
Funding for this research was provided by:
Research Council of Finland’s Flagship InFLAMES (337530, 357910 and 358823, 337530, 357910 and 358823, 337530, 357910 and 358823)
Suomen Kulttuurirahasto
University of Turku Drug Research Doctoral Programme
Research Council of Finland (330902)
Jane ja Aatos Erkon Säätiö (#220026)
National MS Society and the National Stem Cell Foundation (RFA-2203-39281)
- License Information
-
More Information
Article History
Received: 11 April 2025
Accepted: 15 July 2025
First Online: 7 August 2025
Declarations
:
: The authors declare no competing interests.
: The study protocol was approved by the Ethics Committee of the Hospital District of Southwest Finland (Dnro:76/180/2008 and Dnro:86/1800/2017). Written informed consent was obtained from all participants according to the principles of the Declaration of Helsinki. The study for postmortem neuropathological staining was approved by the Ethics Committee of the University of Münster (Ref: 2011-153-f-S).
